We are live on ! Find out more
MGNX icon

MacroGenics

128 hedge funds and large institutions have $68.3M invested in MacroGenics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 128128 (0)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

4.14% less ownership

Funds ownership: 89.45%85.32% (-4.1%)

14% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 42

61% less call options, than puts

Call options by funds: $75K | Put options by funds: $191K

63% less capital invested

Capital invested by funds: $182M → $68.3M (-$114M)

Holders
128
Holders Change
Holders Change %
0%
% of All Funds
1.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
36
Reduced
42
Closed
18
Calls
$75K
Puts
$191K
Net Calls
-$116K
Net Calls Change
+$354K

MGNX Hedge Fund Activity: Q1 2025 in Review

128 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2025, worth a combined $68.3M — down 63% from $182M a quarter earlier.

Fund positioning in MGNX was balanced in Q1 2025: 18 funds opened new positions, 18 closed out, 36 added to existing stakes and 42 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $2.66M. The largest seller was Millennium Management, cutting an estimated $2.98M.

  • 128 institutional investors held MacroGenics (MGNX) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $68.3M of MacroGenics stock for Q1 2025, down 63% quarter-over-quarter.
  • 18 funds opened new MacroGenics positions in Q1 2025 and 18 closed out, a net change of 0 holders.
  • The largest MacroGenics buyer in Q1 2025 was Acadian Asset Management, an estimated $2.66M added.
  • The largest MacroGenics seller in Q1 2025 was Millennium Management, an estimated $2.98M sold.

Based on aggregated 13F filings for Q1 2025.